Documente Academic
Documente Profesional
Documente Cultură
www.pharmacydaily.com.au
Chemist Warehouse
in Sigma sights
AFT rides Maxigesic wave Jen Morris joins NPS
Melbourne-based consultant,
AFT Pharmaceuticals yesterday Brunei, Italy, New Zealand, Serbia, health writer, science researcher,
Sigma Healthcare yesterday
announced its financial results Singapore, United Arab Emirates speaker and consumer advocate
warned that a plan by My Chemist/
for the year ended 31 Mar 2017 and the United Kingdom. Jennifer Morris (pictured) has
Chemist Warehouse (MC/CW) to
with total income increasing 8% to AFT increased investment in R&D been appointed to the NPS
source products from an alternate
$70.8m, although operating losses by 38.0% to $11.6m with sinus MedicineWise Board as a non-
supplier could hit the Sigma bottom
increased from $8.9m in 2015/16 nebuliser NasoSURF completing executive director.
line by as much as $10 million this
to $14.8m this year. Class I Medical Device NPS MedicineWise chair,
year (PD breaking news).
Australian revenue registration in US Peter Turner welcomed Morris
The company confirmed the
grew by 19% to $37.1m and clinical studies in appointment noting that her
launch of legal action against the
and this market now Australia/NZ under way. research work on consumer
key customer, saying it had been in
makes up 54% of total Skin therapy Pascomer perspectives across many aspects
ongoing discussions with Chemist
income, while Maxigesic has earnt Orphan Drug of healthcare will
Warehouse in relation to aspects of
sales more than tripled from 22 Designation from the FDA as well bring valuable
its current Supply Agreement with
million tablets to 74 million. as the European Medicines Agency perspectives to
the group, and had made offers of
The product is now licensed or (EMA). the board.
mediation and binding arbitration
under distribution agreements in The board says it expects AFT will As a guest
which had been rejected.
112 countries and is being sold significantly narrow its losses in lecturer and
As a satisfactory resolution
in eight territories: Australia, FY2018 and return to profitability science writer,
has not been reached, Sigma has
during the FY2018/FY2019 period, Jennifer has
now decided to commence legal
dependent on Australian sales experience raising community
proceedings against MC/CW, the PharmaTrack launch growth and licensing agreements in awareness about healthcare quality
company announced.
Unisys Corporation has territories such as the US & Europe. and safety issues, Turner said.
Sigma maintains that under its
announced the launch of Throughout her career she
agreement with the retailer MC/
PharmaTrack, new software has encouraged public discussion
CW is not entitled to acquire
that combines leading security, Survey - why CPD? about maximising the benefits of
products from another CSO
advanced data analytics and Pharmacists are invited healthcare for all.
wholesaler, with the company
compliance technology in a single, to share their thoughts on Morris, who joined the Board on
seeking declarations and
unified platform to provide life using continuing professional 19 May 2017, succeeds Christine
injunctions for specific performance
sciences and healthcare companies development (CPD) plans through a Walker who is retiring as a director
of the agreement.
enhanced visibility and oversight 5-10 minute survey and contribute after two terms of three years each,
If MC/CW acts in accordance
of the entire global pharmaceutical to research at the Queensland with accolades around her advisor
with their stated intention, the
supply chain and thus help combat University of Technology. role and other contributions to NPS
impact on Sigmas EBIT is expected
theft and counterfeit drugs. CLICK HERE for the brief survey. MedicineWise during her tenure.
to be approximately $5m-$10m per
As a global IT company with a
annum, the company said, along
focus on security solutions, Unisys
with a warning that ongoing legal
costs would also impact earnings.
Sigma values the relationship
says this newest addition to the
Unisys ActiveInsights suite of COPD: demonstrating
with MC/CW and will continue to
solutions arose from an overlap
of industry needs between two devices, evaluating
medicines
provide operational support to MC/
industries in which Unisys has deep
CW in accordance with the terms
domain expertise: life sciences
of the current Supply Agreement
and healthcare, and travel and
which runs to June 2019, the Up to 90% of patients who
transportation.
formal ASX statement added.
According to the World Health use an inhaler device dont
Organisation, dangerous counterfeit
Health tenders drugs make up more than 10% of use it correctly.
The Department of Health has the drug market worldwide while
called for tenders for management supply chain theft, and materials Support your patients
advisory services to conduct the erroneously compromised by poor by adopting best
five-year review of the Health Star environmental quality controls,
Rating system as well as a tender can cost manufacturers billions of practice methods to
for strategic planning consultant dollars annually and likewise put teach and assess
services to support immunisation patients health at risk.
activities nationally through PharmaTrack can help secure the inhaler technique.
Primary Health Networks. supply chain using Unisys cross-
The latter will be expected to platform analytics to identify
develop strategies to address and pre-empt fraudulent activity,
Pharmacy Practice Review
issuing immediate alerts when
under-vaccination in target
populations among other things.
Visit tenders.gov.au for details.
product authentication fails.
See more at unisys.com.
Enrol now
Pharmacy Daily Thursday 25th May 2017 t 1300 799 220 w www.pharmacydaily.com.au page 1
AMH CHILDRENs DOsING
COMPANION - AVAILABLE
IN HARD COPY OR ONLINE
Designed for health care practitioners in
hospital and community settings, the CDC
brings evidence-based, peer-reviewed, up-to-date
dosing information wherever you are.
Pharmacy Daily is Australias favourite pharmacy industry publication. Publisher/Editor in chief: Bruce Piper Editorial: info@pharmacydaily.com.au
Sign up free at www.pharmacydaily.com.au. Managing Editor: Jon Murrie
Postal address: PO Box 1010, Epping, NSW 1710 Australia Reporter: Mal Smith
Street address: Level 2, Suite 1 64 Talavera Rd, Macquarie Park NSW 2113 Australia Contributors: Matt Bell, Rebecca Le Bas, Jasmine ODonoghue
Advertising and Marketing: Sean Harrigan and Melanie Tchakmadjian advertising@pharmacydaily.com.au
P: 1300 799 220 (+61 2 8007 6760) F: 1300 799 221 (+61 2 8007 6769)
Business Manager: Jenny Piper accounts@pharmacydaily.com.au
Part of the Business Publishing Group.
business events news
Pharmacy Daily is a publication of Pharmacy Daily Pty Ltd ABN 97 124 094 604. All content fully protected by copyright. Please obtain written permission to reproduce any material. While every care has been taken in the preparation of
the newsletter no liability can be accepted for errors or omissions. Information is published in good faith to stimulate independent investigation of the matters canvassed. Responsibility for editorial comment is taken by Bruce Piper.
Pharmacy Daily Thursday 25th May 2017 t 1300 799 220 w www.pharmacydaily.com.au page 2